CXCR1/CXCR2受体拮抗剂（G31P）对人前列腺癌增殖的体内外实验研究

刘欣; 邓国英; 杨淑凤; 李芳

您当前的位置：

首页 >

文章列表页 >

CXCR1/CXCR2受体拮抗剂（G31P）对人前列腺癌增殖的体内外实验研究

基础研究 | 更新时间：2024-01-17

- CXCR1/CXCR2受体拮抗剂（G31P）对人前列腺癌增殖的体内外实验研究
- Inhibition study of G31P,a chemokine receptor CXCR1/2 antagonist,in proliferation of human prostate cancer cells in vivo and in vitro
- 重庆医科大学学报 2011年36卷第12期页码：1420-1422
- 作者机构：
  
  1. 大连医科大学基础医学院微生物学教研室
  2. 大连医科大学基础医学院免疫学教研室
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R737.25
- 纸质出版日期：2011，
扫描看全文
[1]刘欣,邓国英,杨淑凤,李芳.CXCR1/CXCR2受体拮抗剂(G31P)对人前列腺癌增殖的体内外实验研究[J].重庆医科大学学报,2011,36(12):1420-1422.

LIU Xin 1, DENG Guo-ying 1, YANG Shu-feng 1, et al. Inhibition study of G31P,a chemokine receptor CXCR1/2 antagonist,in proliferation of human prostate cancer cells in vivo and in vitro[J]. Journal of Chongqing Medical University, 2011,36(12):1420-1422.
[1]刘欣,邓国英,杨淑凤,李芳.CXCR1/CXCR2受体拮抗剂(G31P)对人前列腺癌增殖的体内外实验研究[J].重庆医科大学学报,2011,36(12):1420-1422. DOI：

LIU Xin 1, DENG Guo-ying 1, YANG Shu-feng 1, et al. Inhibition study of G31P,a chemokine receptor CXCR1/2 antagonist,in proliferation of human prostate cancer cells in vivo and in vitro[J]. Journal of Chongqing Medical University, 2011,36(12):1420-1422. DOI：

摘要

目的:探讨CXCR1/CXCR2受体拮抗剂-G31P对人前列腺癌细胞PC-3增殖的体内外抑制作用。方法:采用CCK-8法研究不同浓度G31P对PC-3细胞体外增殖的抑制作用。建立体内绿色荧光蛋白（Green fluorescent protein

GFP）标记人雄激素非依赖性前列腺癌细胞PC-3裸鼠原位移植瘤模型

观察G31P对裸鼠前列腺癌原位移植瘤的体积、重量的影响。结果:CCK-8结果显示100 ng/ml G31P与对照组相比分别作用1、3 d和5 d差异具有统计学意义（1 d P=0.007、3 d P=0.001、5 d P=0.028

均为P<0.05）。前列腺癌PC-3细胞裸鼠模型体内实验显示

与对照组（100μl N.S）相比

G31P处理组（0.5 mg/kg）从给药第18天起能显著抑制前列腺肿瘤的体积（P=0.026

P<0.05）;与对照组相比G31P处理组在抑制前列腺肿瘤重量方面有明显作用（P=0.027

P<0.05）。结论:G31P体内外实验均能抑制人雄激素非依赖性前列腺癌细胞系PC-3的增殖。

Abstract

Objective:To investigate the effect of G31P on the proliferation of the prostate cancer in vivo and in vitro.Methods:The inhibition effect of G31P on the proliferation of PC-3 cell was investigated by CCK-8 assay in vitro.The effect of G31P on the volume and weight of human prostate tumor of nude mice was observed by building orthotopic transplantation tumor model of human androgen-independent prostate cancer PC-3(GFP-labeled) in nude mice.Results:CCK-8 assay found statistically significant difference in inhibiting the proliferation of PC-3 cells between the 100 ng/ml G31P and control group for 1 day(P<0.01)

3 days(P≤0.01) and 5 days(P<0.05).G31P treatment after the 18th day of administration inhibited significantly the prostate tumor volume compared with control group(P<0.05)

and this inhibition was more obvious(P<0.01) after the 24th day of administration in nude mice in vivo.A significant difference was observed between G31P treatment group(P<0.05) and the control group in prostate tumor weight.Conclusion:G31P can inhibit the proliferation of the prostate cancer in vivo and in vitro.

关键词

G31P前列腺癌CXCR1CXCR2

Keywords

G31Pprostate cancerCXCR1CXCR2

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

MTAP在前列腺癌中的表达及对免疫细胞的影响初探

miR-520a-5p通过调控有氧糖酵解诱导前列腺癌细胞多西他赛耐药

甲状腺功能障碍与前列腺癌的因果关联：两样本孟德尔随机化研究

胰凝乳蛋白酶样蛋白酶体的活性作为前列腺癌生物标志物的潜在应用

经直肠和经会阴前列腺穿刺对前列腺癌诊断价值的比较